Cargando…
A Protective Role of Glibenclamide in Inflammation-Associated Injury
Glibenclamide is the most widely used sulfonylurea drug for the treatment of type 2 diabetes mellitus (DM). Recent studies have suggested that glibenclamide reduced adverse neuroinflammation and improved behavioral outcomes following central nervous system (CNS) injury. We reviewed glibenclamide...
Autores principales: | Zhang, Gensheng, Lin, Xiuhui, Zhang, Shufang, Xiu, Huiqing, Pan, Chuli, Cui, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504948/ https://www.ncbi.nlm.nih.gov/pubmed/28740332 http://dx.doi.org/10.1155/2017/3578702 |
Ejemplares similares
-
Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
por: Yang, Jie, et al.
Publicado: (2022) -
The Role of Macrophages in the Pathogenesis of ALI/ARDS
por: Huang, Xiaofang, et al.
Publicado: (2018) -
Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis
por: Zhang, Shufang, et al.
Publicado: (2015) -
Glibenclamide for the Treatment of Acute CNS Injury
por: Kurland, David B., et al.
Publicado: (2013) -
Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence
por: Jha, Ruchira M., et al.
Publicado: (2020)